Medicaid and the Promise for Cure

Area of Science:

• Biomedical science
• Health policy
• Rare disease treatment

Background:

• Cell and gene therapies are transforming rare disease treatment.
• Accessibility and affordability are crucial for successful implementation, especially via Medicaid.

Purpose of the Study:

• To develop a framework for assessing cell and gene therapies.
• To evaluate payment options for these therapies.
• To ensure equitable access through Medicaid programs.

Main Methods:

• Review of 29 peer-reviewed articles and federal reports.
• Incorporation of expertise from state Medicaid chief medical officers and medical directors.
• Analysis across 5 diverse states.

Main Results:

• Policy recommendations developed across safety, effectiveness, population health, access, and budget domains.
• A framework for assessing and implementing cell and gene therapies is presented.
• Focus on balancing innovation with affordability and equitable access.

Conclusions:

• Proposed policy changes aim to ensure fair access to innovative therapies for rare diseases.
• Medicaid programs play a vital role in facilitating access to life-changing treatments.
• Thoughtful implementation is key to realizing the full potential of cell and gene therapies.